Notice of Application to Register a Trade Name Product (Notice No. MPI ACVM 27)
Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:
Trade Name: Senvelgo 15mg/mL Oral Solution for Cats
Reference: A011974
Active Ingredients and Concentrations:
15mg/mL velagliflozin (as velagliflozin L-proline H2O)
Formulation Type: Aqueous solution
Application method/administration route:
The recommended dosing regimen is 1mg/kg body weight orally once daily
Use Claim:
For the reduction in hyperglycaemia and improvement in associated clinical signs in otherwise healthy cats with non-insulin dependent diabetes mellitus
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.
The following address is:
ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.
MPI encourages submission by email.
The applicant’s address for service is:
Boehringer Ingelheim Animal Health New Zealand Limited, Level 2, 3 Te Kehu Way, Mount Wellington, Auckland 1060. Postal Address: PO Box 76211, Manukau, Auckland 2241.
Dated at Wellington this 19th day of September 2024.
SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).